Business (Details Narrative) (USD $)	Sep. 21, 2011	Jun. 30, 2011	Dec. 31, 2010	Dec. 31, 2009
Accounting Policies [Abstract]
Acquisition of outstanding common stock of BioZone Labs		$ 100
Exchanged outstanding stock into shares of common stock		19,266,055
Outstanding membership interests of Equalan and Equachem		100.00%
Exchanged membership interest of Equalan for common stock		1,027,523
Exchanged membership interest of Equachem for common stock		385,321
Outstanding membership interests of BetaZone		45.00%
Exchanged membership interest of BetaZone for common stock		321,101
Total number of shares from acquisition		21,000,000
Fair value of acquisition		2,000,000
Common stock issued for delay in filing Form S-1	13,914
Price per share of common stock issued for delay	$ 0.50
Acquired brands	110,000
Acquired customer relationships	$ 172,800
Number of shares outstanding, original amount			21,000,000	44,749,999
Number of shares outstanding, reduced amount				21,000,000